Abraham Mittelman

Title: Abraham Mittelman: Innovator in Immunological Adjuvants

Introduction

Abraham Mittelman is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of immunology through his innovative work on synthetic toll-like receptor-4 (TLR-4) agonist peptides. His research focuses on developing novel immunological adjuvants that enhance immune responses.

Latest Patents

Mittelman holds 1 patent for his invention titled "Synthetic toll-like receptor-4 (TLR-4) agonist peptides." This invention provides novel immunological adjuvants and methods for identifying such adjuvants. It further outlines methods and compositions for eliciting an immune response to an immunogen using these novel adjuvants. The adjuvants can be employed with various immunogens, including proteins, peptides, lipids, and carbohydrates. The immunogen can be derived from a virus, cancer, or diseased cell, and the elicited immune response can be cellular, humoral, or both.

Career Highlights

Mittelman is currently associated with Av Therapeutics, Inc., where he continues to advance his research in immunology. His work has the potential to impact vaccine development and therapeutic strategies for various diseases.

Collaborations

Some of his notable coworkers include Raj Tiwari and Robert Suriano, who contribute to the innovative environment at Av Therapeutics, Inc.

Conclusion

Abraham Mittelman's contributions to immunological adjuvants represent a significant advancement in the field of immunology. His innovative work continues to pave the way for new therapeutic approaches.